All posts by imreal

American Gene Technologies’ HIV Cure Clinical Trial Enters Critical Phase: Withdrawing Participants from Antiretrovirals


News Image

This is the next logical step in the trial’s progression. By withdrawing these patients’ antiretrovirals we can demonstrate whether our AGT103-T gene therapy leads to a cure. – Dr. Marcus A. Conant, Chief Medical Officer at American Gene Technologies

American Gene Technologies, a clinical-stage biotechnology company, has reached a turning point in its HIV cure clinical trial: it began withdrawing participants from their antiretroviral drugs earlier this month. This clinical protocol, technically known as analytic treatment interruption (ATI), may ultimately determine if this gene therapy treatment can cure HIV.

“This is the next logical step in the trial’s progression,” explained Dr. Marcus A. Conant, Chief Medical Officer at American Gene Technologies. “By withdrawing these patients’ antiretrovirals we can demonstrate whether our AGT103-T gene therapy will lead to a cure.”

In February 2022, the independent Institutional Review Board (IRB) overseeing the clinical trial approved the company to proceed with the ATI. Seven patients have received AGT103-T so far. None have experienced any serious adverse events, thereby demonstrating the therapy’s safety. Blood markers in the treated patients have provided a view into how the cell therapy is responding in their bodies. So far, the data has confirmed that the cells are properly engrafting, persisting, and seem to be remaining uninfected while reacting to, and likely fighting HIV the way scientists expected.

“This is a critical step in our mission to cure HIV using gene therapy,” said American Gene Technologies CEO Jeff Galvin. “We’ll monitor participants carefully, and within the next few months we’ll begin to know how close we are to reaching our dream of curing HIV. If participants respond as we expect, they may no longer need to take their antiretroviral medications, and could remain immune to HIV for life without further treatment. If we obtain that result, we may have achieved the most exciting development in HIV research in decades. This milestone could lead to a reliable cure for HIV that returns infected individuals to a normal life without risk of ever developing AIDS or infecting another person.”

Participation in the treatment withdrawal study by the Phase 1 clinical trial participants is voluntary. To proceed with a monitored antiretroviral treatment interruption, participants re-enroll with a new informed consent agreement that outlines the risks and details of the updated ATI protocol.

Phase 1 Trial Background

  • Overview: Designated the RePAIR trial (Restore Potent Antiviral Immune Responses, NCT04561258), American Gene Technologies’ first-in-human study for AGT103-T is currently underway at trial sites in the Maryland / Washington, D.C. area. Participants in the Phase 1 trial receive a single infusion of their own HIV-specific CD4 T cells after those cells are enriched and genetically modified to resist infection. Without any observed negative or adverse events, the DSMB has allowed the trial to continue without adjustments or delays.
  • Focus: The primary endpoints of RePAIR are safety and efficacy. Testing related to secondary endpoints evaluates responses to treatment, including changes in the immune response to HIV.
  • Participant Criteria: Participants range in age from 18 to 60 and include males and females. Participants have been diagnosed with HIV for at least three years and must have taken HIV antiretroviral medication for more than two years prior to enrollment. Participants cannot be pregnant and must be available to attend 17 study visits over a 10-month period. Anticipated completion of treatments in the Phase 1 study is Q3 2022, although final data and long-term monitoring will continue. The Phase 1 study will include up to 18 participants. (The recruitment status of the Phase 1 RePAIR clinical trial, along with information on the trial sites, can be found on the official ClinicalTrials.gov website.)
  • Timeframe: Participants treated with AGT103-T are followed for 6 months in this safety study before enrolling in an FDA-mandated, 15-year, long-term follow up (required for all gene therapy trials). The first infusion occurred in May 2021, the second in August 2021, the third in September 2021, the fourth and fifth in November 2021, the sixth in February 2022 and the seventh in May 2022. An analytic treatment interruption (ATI) study to determine product efficacy has been approved. American Gene Technologies expects to reveal results of the ATI by the end of this year (2022).

About HIV

According to UNAIDS, approximately 37.7 million people worldwide live with HIV/AIDS. In the United States, government statistics show 1.2 million people have HIV and estimate that 34,800 Americans were newly infected with HIV in 2019. Across the globe, UNAIDS estimates that approximately 1.5 million individuals were newly infected with HIV in 2020. The Washington D.C./Baltimore area is often cited as a ‘hot spot’ for HIV, with Washington, D.C., having the highest rate of infection at nearly 46 cases per 100,000 population and Baltimore City having rates of 17 cases per 100,000. Maryland also ranks sixth among U.S. states and territories in HIV diagnosis rates, with more than 900 new cases in 2019 alone, according to the Maryland Department of Health.

Since the late 1980s, antiretroviral drugs have restored quality of life to persons living with HIV and, in some cases, have even been used to prevent new infections. However, no approved treatment has demonstrated the ability to cure HIV. American Gene Technologies is committed to addressing this unmet medical need.

About AGT103-T

AGT103-T is a genetically modified cell product made from a person’s own cells. American Gene Technologies’ unique approach focuses on permanently repairing the key immune system damage caused by HIV. American Gene Technologies’ goal is to develop a gene therapy capable of repairing the immune system so it will provide natural control over HIV replication.

About American Gene Technologies

American Gene Technologies is a gene therapy company with a proprietary gene-delivery platform for rapid development of gene therapies to cure infectious diseases, cancers, and inherited disorders. Its mission is to transform people’s lives through genetic medicines that rid the body of disease. American Gene Technologies has been granted four patents for the technology used to make AGT103-T and 11 patents for its unique immuno-oncology approach to stimulate gamma-delta (γδ) T cells to destroy a variety of solid tumors. The company has developed a synthetic gene for treating Phenylketonuria (PKU), a debilitating inherited disease. American Gene Technologies’ treatment for PKU has been granted Orphan Drug Designation by the Food and Drug Administration (FDA), and it is expected to reach the clinic in 2023.

Video About American Gene Technologies’ Work: https://youtu.be/fiA2s7JCkJ8

Share article on social media or email:

AI Technology Gaining Traction in Vet Clinics with Studies Confirming Accuracy and Expanding Pet Applications


AI report

Virtual Radiology Canine Cardiopulmonary Screening

The present study demonstrated that AI software correctly identified cardiogenic pulmonary edema from canine thoracic radiographs in approximately every 9 out of 10 cases diagnosed with “CPE” by a board-certified veterinary radiologist.

The study, released earlier this year, analyzed 500 consecutive canine thoracic radiographs made after-hours by The Emergency Department at the Animal Medical Center in San Diego, CA. Accuracy, sensitivity, and specificity of the AI-based software compared to radiologist diagnosis were 92.3%, 91.3%, and 92.4%, respectively. These findings supported using AI software screening for thoracic radiographs of dogs with suspected cardiogenic pulmonary edema to assist with short-term decision-making when a radiologist is unavailable. Following this earlier study, a second study was conducted with the Tufts University Cummings School of Veterinary Medicine that showed that the AI algorithm with Vetology was able to determine the presence of pleural effusion with 88.7% accuracy (P< 0.05) in thoracic radiographs in dogs. Both studies can be found on the vetology.ai website.

“As the demand for teleradiology increases each year, the number of graduating ACVR board certified specialists cannot meet this demand,” said Dr. Seth Wallack, CEO and Founder of Vetology.ai. “The mission of our team of radiologists is to address increasing pressure on case load demand to help clinics, emergency, and specialty hospitals provide timely answers while the patient is still in the clinic. Our easy-to-use technology thinks like a radiologist and can address this need. We are thrilled with the outcome of these studies, which validate the effectiveness and accuracy of leveraging technology to enhance patient care.”

It is increasingly easy for a vet clinic to adopt and use AI technology. With vetology.ai for example, the set up takes about 10 minutes, and a vet clinic can be up and running in the same day. Vetology.ai configures the x-ray system in the clinic to send the x-rays to the Vetology platform, where they are viewable anywhere. Once the images are received, the artificial intelligence gets to work using the knowledge that it has learned from Vetology’s team of radiologists and millions of reads within the Vetology database. A detailed report is generated in 5 minutes. In addition, Patterson Veterinary offers Vetology AI Radiograph Analysis Software as part of their company’s growing portfolio of software solutions, and Sedecal x-ray systems come pre-configured for AI quick reads.

AI technology is increasingly being used by vet clinics across the country, with a growing level of success. “Vetology’s AI solution helps me in my practice by significantly expediting the answers we are looking for,” said Dr. Julie Brehrer, practicing veterinarian for 25 years. “Within minutes I can confirm or rule out certain diagnoses, and then proceed with treatment promptly and appropriate and feel confident I’m going down the correct path.” In addition, vet clinics are beginning to see positive feedback from their clients. “Clients are more compliant when they can see a written report to take home,” said Dr. Christina Haney, Alicia Pacific Veterinary Center in Laguna Niguel, California. “They are more readily willing to pay for the radiographs to be taken, our radiology compliance has gone up, and our medicine has improved as a result.” More customer testimonials and success stories can be found on the vetology.ai website.

For press inquiries, contact Eric Goldman at eric.goldman@vetology.net

For more information, visit vetology.ai.

Share article on social media or email:

NovaBone Announces New VP of Sales of Their Orthopedics Division


NovaBone Announces New VP of Sales of Their Orthopedics Division Sean Finnerty

Leaders in biologic medical devices, NovaBone, is pleased to announce Sean Finnerty as the company’s new Vice President of Sales in their Orthopedics Division. As the organization continues to grow and focus on developing biomaterials that meet the specific needs of orthopedic and dental surgeons, Finnerty’s addition to the leadership team was a strategic move to further improve their orthopedic sector.

With nearly two decades of experience in various orthopedic specialties, including Spine and Extremities, Mr. Finnerty brings to NovaBone an important skill set that will take the orthopedics division to the next level. Sean is a graduate of the United States Naval Academy and served as an officer in the United States Navy directly contributing to Operation Enduring Freedom. 

“It gives me great pleasure to announce our new VP of Sales, Orthopedics, Sean Finnerty. In Sean’s new role he will have global responsibility for the orthopedic business and will be charged with leading the next chapter of NovaBone’s growth journey.  Sean will also serve on NovaBone’s Board of Directors.” – NovaBone CEO, Brian Carlisle

As the organization expands and furthers its reach into the orthopedic and dental sectors, its new leadership team will play a vital part in the organization’s success and mission to develop biomaterials that harness the body’s natural healing process to better meet the needs of surgeons.

For more information on the new team member and his position, visit NovaBone.com.

About NovaBone

NovaBone, a Halma company, is privately held and based in Florida since 2002. NovaBone developed the first bioactive synthetic bone graft offered to the orthopedic community and has long been at the forefront of bioactive glass bone graft devices. It has developed numerous formulations and delivery systems of its patented, bioactive technology platform that results in accelerated bone growth. In total, their exclusively formulated bone graft substitute has been used for the repair of osseous defects throughout the skeletal system for over a decade and used in over a million clinical applications with unparalleled success validating the safety and efficacy of NovaBone’s technology.

Share article on social media or email:

How to Prepare Older Loved Ones for Severe Weather and Emergencies


Tornadoes, hurricanes, wildfires and other severe weather events can cause significant emotional, physical and financial distress, which is why it’s important to prepare and not let it take you by surprise. Having a plan in place is key to staying safe and reducing impact. However, according to a recent report from the National Poll on Healthy Aging, many older adults have not taken key steps recommended by disaster preparedness agencies. Less than half of respondents said they had signed up to receive alerts through their community’s emergency warning system, and three in four individuals who use medical equipment that requires electricity did not have an alternative power source.

These statistics can be concerning, especially as 2022 has already brought powerful floods, terrifying droughts, and unusually early heat waves globally – and it seems there’s more extreme weather on the way. In fact, the National Oceanic and Atmospheric Administration predicted above-normal temperatures for most of the U.S. during the summer and expects above-average hurricane activity this year, forecasting a likely range of 14-21 named storms. For older adults, especially those who live alone, preparation and taking extra steps to ensure your safety should not be put off until tomorrow.

“Navigating severe weather and emergencies can be extremely stressful, but for older adults who may need to consider mobility issues, vision impairment, medication management, and other challenges, it may be harder to prepare and respond to these events,” said Lakelyn Hogan Eichenberger, Ph.D., gerontologist and caregiving advocate at Home Instead, Inc. “Creating a plan, organizing important documents and relying on the support of friends, family members, and caregivers, can go a long way in helping seniors feel safe.”

Hogan Eichenberger outlines helpful tips for seniors to prepare for extreme weather:

Step 1: Create a Communication Plan

  • Create a plan for where you will go, who you will call, and what you will take with you if you need to leave your home in the event of a weather emergency, and practice with a loved one. Have a back-up plan for who you can check in with if a family member is unavailable – either a neighbor, caregiver, or family friend.
  • Don’t rely on your cell phone contact list. Create a hard copy with contact information for family members and friends and leave a copy by the phone and in your emergency kit. Make sure all family caregivers have this list, as well as neighbors and professional caregivers who may be checking in.
  • Designate one local contact and one out-of-town contact to call during or after a disaster. Long-distance calls may be easier to make when local areas are impacted. Ensure everyone is on board with this chain of communication.
  • Discuss and revise your plan annually to assess any physical changes or limitations that may require alterations to the plan. Situations change, so it is a good idea to revisit arrangements to confirm it is still the best course of action and everyone is kept in the loop.

Step 2: Be Prepared to Evacuate

  • Pack an emergency ready kit with medications, essential medical supplies, non-perishable snacks, bottled water, local maps, a flashlight with extra batteries, and a cell phone with a charger and backup battery. Include important documents such as identification, insurance cards, key financial information, emergency contact information, and a copy of your will.
  • Plan on where you will go during an evacuation. Keep a copy of exit routes and meeting locations in a convenient place. If not ordered to evacuate, go to the basement during a tornado. During a hurricane or tropical storm, sheltering in an interior room, closet, or hallway is best.

Step 3: Stay Informed

  • Be aware of emergency resources, such as local plans for emergency alerts, evacuation, and shelter resources available in your community. Visit your local Area Agency on Aging or area community center for resources and recommendations for your region.
  • Set up weather alerts on your phone to notify you of severe weather and for live updates. Out-of-town family can also set up weather alerts for a loved one’s area, so they are aware of when there is an emergency.

In the event of a natural disaster or weather emergency, having a professional caregiver in the home to support an older loved one can be comforting. A professional caregiver can help provide a sense of safety, keep a senior’s routine as normal as possible, and regularly update family members. For more information on services a caregiver can provide and additional resources, visit https://www.homeinstead.com/home-care-services.

###

ABOUT HOME INSTEAD, AN HONOR COMPANY

Home Instead, Inc. and its parent company, Honor, are expanding the world’s capacity to care. With the world’s largest home care network and the most advanced care platform, Honor and Home Instead are revolutionizing care for older adults, their families, and Care Professionals. Home Instead, Inc. is the premier home care franchisor through its network of independently owned and operated Home Instead franchise businesses. Combined, the network has more than 100,000 Care Professionals across 13

Share article on social media or email:

American College of Lifestyle Medicine’s Rapidly Growing Health Systems Council Reaches 65 Founding Members in First Year


News Image

“Lifestyle medicine is foundational to our organization’s vision to make health simple, affordable, equitable and exceptional.”–Kristi Artz, MD, DipABLM, Medical Director, Spectrum Health Lifestyle Medicine

The American College of Lifestyle Medicine (ACLM) today announced that 65 health systems have joined its Health Systems Council (HSC) as founding members. The council was launched in May 2021 to support the pioneering trend of implementing lifestyle medicine into some of the largest and most innovative health organizations in the United States.

Together, the HSC 65 founding member health systems will lead the transition to high-value care through the integration of evidence-based lifestyle medicine into the creation of lifestyle medicine programs and centers, employee wellness and expanded research into the therapeutic impacts of lifestyle medicine.

“The exceptional growth of the Health Systems Council in the one year since its inception demonstrates the recognition by a diverse constellation of health systems in the U.S. that the current model of healthcare delivery is neither effective nor sustainable,” said HSC Advisory Board member and ACLM Past-President Dexter Shurney, MD, MBA, MPH, FACLM, DipABLM. “Already in this growing community the exchange of ideas, strategies and best practices for the implementation of innovative, scalable and successful lifestyle medicine programs has helped HSC member health systems identify practical solutions to many common barriers. I am excited to see the HSC continue to evolve as we bring more health systems to the table in the second year.”

Lifestyle medicine is a medical specialty that uses therapeutic lifestyle interventions as a primary modality to treat chronic conditions including, but not limited to, cardiovascular diseases, type 2 diabetes, and obesity. Lifestyle medicine-certified clinicians are trained to apply evidence-based, whole-person, prescriptive lifestyle change to treat and, when used intensively, often reverse such conditions. Applying the six pillars of lifestyle medicine—a whole-food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, avoidance of risky substances and positive social connections—also provides effective prevention for these conditions.

Lifestyle medicine can address up to 80% of chronic diseases. A lifestyle medicine approach to population care has the potential to arrest the decades-long rise in the prevalence of chronic conditions and their burdensome costs. Patient and provider satisfaction often result from a lifestyle medicine approach, which strongly aligns the field with the Quintuple Aim of better health outcomes, lower cost, improved patient satisfaction, improved provider well-being, and advancement of health equity, in addition to its alignment with planetary health.

“Knowing we’ve had to pave our own paths forward and enter uncharted territory many times, we have enjoyed sharing our experience and lessons learned with others, as well as learn from those who may be further down the path than we are in particular areas,” said Marcy Madrid, Vice President, Community Health at Midland Health.

HSC membership also provides health systems access to the newest lifestyle medicine research literature, assistance identifying grant funding opportunities, advances in evidence-based lifestyle medicine education and training, networking opportunities and more. Health systems of various sizes and stages of integration come together in a collaborative learning community of practice to improve health outcomes using lifestyle-based interventions as a primary modality.

While lifestyle medicine is not new, large-scale implementation of these evidence-based modalities into health systems is one of the greatest pioneering initiatives in the health care industry today and presents a number of learning opportunities and challenges. The council provides a platform for health systems to exchange state-of-the-art practices and resources, identify pragmatic solutions to common barriers, and accelerate the integration and implementation of lifestyle medicine therapeutic modalities within their organizations and their communities.

“Lifestyle medicine is foundational to our organization’s vision to make health simple, affordable, equitable and exceptional,” said Kristi Artz, MD, DipABLM, Medical Director, Spectrum Health Lifestyle Medicine and HSC Advisory Board member.

Council participants do not need to be ACLM members but, to be eligible, health systems must include at least one hospital and at least one group of physicians providing comprehensive care, and who are connected with each other and with the hospital through common ownership or joint management. They can apply to join by reviewing the Health Systems Council brochure which contains a link to the Health Systems Council interest form. It is free to join the HSC.

Founding Member Health Systems are:


  • AdventHealth
  • Adventist Health
  • Appalachian Regional Healthcare
  • Atrium Health
  • Banner Health Wyoming Medical Center
  • Barnes Jewish Hospital / WashU Living Well Center
  • Baylor Scott & White Health
  • Bellin Health
  • Box Butte General Hospital
  • Children’s Hospital at Montefiore
  • Cone Health
  • ECU Health
  • Emory Healthcare
  • Eskenazi Health
  • Henry Ford Health System
  • Hospital for Special Surgery
  • Houston Methodist
  • Inova Health System
  • Intermountain Healthcare
  • Jackson Health System
  • Kaiser Permanente Northern California
  • Kaiser Permanente Southern California
  • Lakeland Regional Health
  • Lifespan Health System
  • Loma Linda University Medical Center
  • Mary Free Bed Rehabilitation Hospital
  • Massachusetts General Hospital
  • Mayo Clinic
  • MedStar Health
  • Memorial Health System
  • Middlesex Health
  • Midland Health
  • Monument Health
  • Mount Sinai Health System
  • MultiCare Health System
  • MyMichigan Health
  • North Mississippi Health Services
  • Novant Health
  • NYC Health + Hospitals
  • Oregon Health & Sciences University
  • Orlando Health
  • Owensboro Health
  • Prisma Health
  • ProMedica
  • Providence
  • Renown Health
  • Rochester Regional Health
  • Rush University System for Health
  • Saint Francis Health System
  • Sharp HealthCare
  • Spectrum Health
  • St. Dominic’s Health Services
  • St. John’s Episcopal Hospital
  • St. John’s Health
  • St. Joseph Mercy Ann Arbor
  • St. Luke’s Health System
  • St. Luke’s University Health Network
  • UCF Health
  • UConn Health
  • University of California San Diego Health
  • University of Mississippi Medical Center
  • University of Toledo Medical Center
  • University of Utah Health
  • UPMC Health
  • WellSpan Health

ABOUT ACLM–The American College of Lifestyle Medicine is the nation’s medical professional society advancing lifestyle medicine as the foundation for a redesigned, value-based and equitable healthcare delivery system, leading to whole person health. ACLM educates, equips, empowers and supports its members through quality, evidence-based education, certification and research to identify and eradicate the root cause of chronic disease, with a clinical outcome goal of health restoration as opposed to disease management.

Share article on social media or email:

Orivet Partners with ShipBob to Improve Distribution and Meet Demand in Europe


“We feel lucky to be able to depend on our partners at ShipBob, said Dr. Noam Pik CEO of Orivet.

Orivet Genetic Pet Care, a leader in international personalized medicine and genetic testing, is proud to announce a new partnership with ShipBob. ShipBob is a leader in cloud-based logistics designed for small and medium-sized eCommerce businesses, providing businesses with more efficient fulfillment capabilities.

The partnership was established due to Orivet’s rising popularity across Europe and the need to meet the demand for its line of industry-leading genetic testing products. By utilizing ShipBob’s strong fulfillment center network, comprised of over 24 facilities across the United States, United Kingdom and Europe, Orivet can avoid many supply chain disruptions still plaguing industries worldwide.

“We feel lucky to be able to depend on our partners at ShipBob, said Dr. Noam Pik CEO of Orivet. “It’ll be much easier to connect with our customers – both pet owners and breeders – and get them the products they need much more quickly.”

About Orivet Genetic Pet Care

Orivet Genetic Pet Care is a leading personalized-medicine organization offering innovative health care solutions for breeders, veterinarians, and pet owners. The organization was founded in 2010, on the premise that each pet is unique, with its own set of specific traits, behaviors, genetic health needs, and inherent risks. Orivet works with veterinarians, pet owners, and responsible pet breeders to provide practical, evidence-based platforms focused on identifying risk and improving clinical outcomes.

To learn more about Orivet Genetic Pet Care, please visit https://www.orivet.com

Share article on social media or email:

2022 Speedway Miracle Tournament and Celebration Dinner Raises $3 Million for Children’s Miracle Network Hospitals®


Speedway Miracle Children

At Children’s Miracle Network Hospitals, we’re on the frontlines when it comes to protecting the health of future generations. But we can’t do it alone.

Children’s Miracle Network Hospitals (CMN Hospitals) today announced that the 2022 Speedway Miracle Tournament and Celebration Dinner raised nearly $3 million to support its member children’s hospitals across the country. The annual event, hosted last month in Kettering, Ohio, by Speedway, part of the 7-Eleven, Inc. family of brands, is one of the largest charity golf tournaments in the nation. Combined with in-store fundraising campaigns conducted by Speedway – and through the generosity of customers, vendor partners and associates – the company has raised more than $150 million for Children’s Miracle Network Hospitals since 1991.

“At Children’s Miracle Network Hospitals, we’re on the frontlines when it comes to protecting the health of future generations. But we can’t do it alone. For decades, Speedway has been an integral partner for our organization, helping to raise donations that make a huge impact in providing life-saving pediatric care at our hospitals across the country,” said Teri Nestel, President & CEO of Children’s Miracle Network Hospitals. “Each year, we look forward to the Speedway Miracle Tournament and Celebration Dinner. Not only does Speedway and its vendor partners go above and beyond to make the kids and families feel special, but the funds raised help to make sure local member children’s hospitals are supported so that kids across the country continue to receive the best care possible – no matter life’s circumstances.”

Each year, the highlight of the Speedway Miracle Tournament and Celebration Dinner is the Speedway Miracle Children, who are celebrated throughout the two days and serve as the face of their local member children’s hospital. More than 50 children and their families attended this year’s event, sharing their personal stories and highlighting the significant impact Speedway’s donations have made in funding critical treatments and services at member children’s hospitals. Nearly 600 participating golfers had the opportunity to meet and interact with them while out on the golf course, and the kids also were honored with an inspirational medal ceremony at the dinner.

“Convenience may be our focus, but serving is our business, and that business extends beyond our stores and into the communities where our customers, employees and franchisees live and work,” said Rankin Gasaway, executive vice president and chief administrative officer for 7-Eleven, Inc. “We pride ourselves on being a great neighbor and leading through service to make the world a better place. Our 31-year-long partnership with Children’s Miracle Network Hospitals allows us the opportunity to host events and celebrations that help to further their mission, and all funds raised this year will provide critical, lifesaving equipment and much needed resources to the communities we serve.”

# # #

About Children’s Miracle Network Hospitals:

Children’s Miracle Network Hospitals® raises funds for 170 children’s hospitals that support the health of 10 million kids each year across the U.S. and Canada. Donations go to local hospitals to fund critical life-saving treatments and healthcare services, along with innovative research, vital pediatric medical equipment, child life services that put kids’ and families’ minds at ease during difficult hospital stays and financial assistance for families who could not otherwise afford these health services. When we improve the health of all children and allow them the opportunity to reach their full potential, we also improve our communities for years to come. Together, we can change kids’ health. Together, we can change the future. To learn about Children’s Miracle Network Hospitals and your local children’s hospital, visit cmnhospitals.org.

About 7-Eleven, Inc.:

7-Eleven, Inc. is the premier name in the convenience-retailing industry. Based in Irving, Texas, 7-Eleven operates, franchises and/or licenses more than 14,000 stores in the U.S. and Canada. In addition to 7-Eleven® stores, 7-Eleven, Inc. operates and franchises Speedway®, Stripes®, Laredo Taco Company® and Raise the Roost® Chicken and Biscuits locations. Known for its iconic brands such as Slurpee®, Big Bite® and Big Gulp®, 7-Eleven has expanded into high-quality sandwiches, salads, side dishes, cut fruit and protein boxes, as well as pizza, chicken wings and mini beef tacos. 7-Eleven offers customers industry-leading private brand products under the 7-Select™ brand including healthy options, decadent treats and everyday favorites at an outstanding value. Customers can earn and redeem points on various items in stores nationwide through its 7Rewards® loyalty program with more than 50 million members, place an order in the 7NOW® delivery app in over 2,000 cities, or rely on 7-Eleven for bill payment service, self-service lockers and other convenient services. Find out more online at http://www.7-Eleven.com.

Share article on social media or email:

Village Dermatology Welcomes New Surgical Physician Assistant


The Surgical Department at Village Dermatology continues to grow as it has added Lelie Welden, PA-C, Certified Surgical Physician Assistant, to support the growing need for surgical dermatology patient coverage. “We are extremely excited to welcome Lelie to our team and help support Dr. Rachel Pflederer in our Surgical Department,” explained Dr. Jenny Sobera. “The need for quality surgical dermatology care is always high, and we have expanded our team to support that need in our community. Lelie is integral to our overall dermatology practice, and we are fortunate to have her talents here at Village Dermatology.”

Lelie was trained locally at the University of Alabama-Birmingham, where she received her Master’s Degree in Physician Assistant Studies and is certified by the National Commission on Certification of Physician Assistants. Lelie is also an active member of the American Academy of Physician Assistants and the Society of Dermatology Physician Assistants.

“I am thrilled to be part of the Village Dermatology team here in Birmingham,” stated Lelie. “Our ability to treat medical and surgical dermatology patients with one comprehensive team means that our patients receive the best medical care possible for their dermatology needs.”

Village Dermatology has been expanding its surgical dermatology department over the last 12 months to support the growing demand for comprehensive dermatology care in the Birmingham area. The expansion of the surgical department plus other departments like clinical research has positioned Village Dermatology as one of the leaders in dermatology care in central Alabama.

About Village Dermatology

Village Dermatology is a Forefront Dermatology practice in Birmingham, AL. Village Dermatology serves patients across the greater Birmingham area with medical and cosmetic dermatology services. To serve their patients better, Village Dermatology has 4 locations for your convenience: 2900 Cahaba Road, Mountain Brook, AL 35223; 2217 Decatur Hwy Suite 123 Gardendale, AL 35071; and 150 Gilbreath Drive, Oneonta, AL 35121.

For more information, please visit https://www.villagedermatology.net.

Share article on social media or email:

JASE Medical launches new additions to the Jase Case, the unique medical preparedness emergency kit


“We are excited to be able to offer new treatment options. These additional treatment options means we now cover all of the most common ailments for world travelers or others who may find difficulty accessing prompt medical care,” – Shawn Rowland, M.D., founder and CEO of JASE Medical.

JASE Medical, a unique online medical service that offers life-saving medications to help consumers be medically prepared during the unexpected, today announced new additions to their emergency medications kit, the Jase Case.

Many consumers would not be prepared if they found themselves cut off from modern medical care and treatment during foreign travel, outdoor adventures, natural disasters, and pandemics. JASE Medical empowers people to care for themselves and their loved ones during these scenarios. United States and Canada residents can use JASE Medical’s service to consult with a board-certified physician online and obtain emergency antibiotics in the Jase Case. The JASE Case already includes a long-term supply of standard antibiotics – Amoxicillin-Clavulanate, Azithromycin, Ciprofloxacin, Doxycycline, and Metronidazole – to treat the most common and most deadly bacterial infections. In addition, JASE now offers these add-on options:


  • Fluconazole. Used to treat common yeast infections (such as vaginal candidiasis)
  • Ondansetron (Zofran). Used to treat: Nausea and vomiting

“We are excited to be able to offer new treatment options,” said Shawn Rowland, M.D., founder and CEO of JASE Medical. “These additional treatment options mean we now cover all of the most common ailments for world travelers or others who may find difficulty accessing prompt medical care.”

As a board-certified family medicine physician, Dr. Rowland has seen first-hand how timely access to medical care and treatment is lacking in our country – and decided to change that by founding JASE Medical. The service is supported by a highly-qualified group of experts in both infectious disease and primary care – including experts from Harvard, Columbia, Stanford, and the Mayo Clinic. Together, they are leading the way in medical preparedness for individuals of all ages and backgrounds making sure they have access to life-saving medications to care for themselves and their loved ones during the unexpected.

To order JASE Medical emergency medications kit, visit jasemedical.com

About JASE Medical:

Founded in 2020 in Utah, JASE Medical was created with the mission of empowering people to be better prepared medically. This one-of-a-kind medical service was developed in partnership with world-class medical experts from Boston’s Children’s Hospital, Columbia University, Harvard Medical School, Mayo Clinic, Stanford University, and The University of Utah. JASE Medical offers U.S. and Canadian residents the opportunity to consult with a board-certified doctor online and obtain emergency antibiotics in advance of travel or for emergency use. JASE Medical will soon also be available to Australian residents.

Press Contact

Jane Weese

jane.weese@jasemedical.com

385-349-6272

Share article on social media or email:

Memorial Cancer Institute First in Florida to Achieve Certification through American Society of Clinical Oncology’s Patient-Centered Cancer Care Pilot


Memorial Cancer Institute Achieves ASCO Patient-Centered Cancer Care Certification

“We are thrilled to be among the first in the nation to be recognized for our commitment to high-quality cancer care by demonstrating our program’s ability to meet rigorous care delivery and quality improvement standards,” said Meredith B Feinberg, Vice President, Memorial Cancer Institute.

Memorial Cancer Institute is among the first nine oncology sites in the nation and the first in Florida to achieve certification through the American Society of Clinical Oncology’s (ASCO) Patient-Centered Cancer Care Certification pilot based on its adherence to oncology medical home (OMH) standards, a single set of comprehensive, expert-backed standards for patient-centered care delivery. Published by ASCO and the Community Oncology Alliance (COA), these rigorous standards focus on seven domains of cancer care: patient engagement; availability and access to care; evidence-based medicine; equitable and comprehensive team-based care; quality improvement; goals of care and palliative and end-of-life care; and chemotherapy safety.

“We are thrilled to be among the first in the nation to be recognized for our commitment to high-quality cancer care by demonstrating our program’s ability to meet rigorous care delivery and quality improvement standards,” said Meredith B Feinberg, Vice President, Memorial Cancer Institute and Moffitt Malignant Hematology and Cellular Therapy at Memorial Healthcare System. “Every member of the Memorial Cancer Institute team, from physicians and healthcare professionals to our administrative staff made significant contributions to ensure this journey ultimately benefits our patients.”

Beginning in July 2021, Memorial Cancer Institute, along with 11 other oncology sites in the United States, prepared for on-site surveys to evaluate performance relative to each ASCO-COA Oncology Medical Home Standards of care. With guidance from surveyors, Memorial Cancer Institute further transformed cancer care delivery, including the development of improved workflows, staff education and training on the new initiatives, and compliance with data monitoring to demonstrate success. To achieve certification, Memorial met 17 rigorous care delivery standards and 22 chemotherapy safety standards.

Memorial Cancer Institute will continue to work with ASCO leaders on these important value-based initiatives to review quality improvement initiatives, patient satisfaction surveys and oncology clinical pathways utilization, as well as data on quality measures, such as advance care planning, depression screening, chemotherapy in the last 14 days of life, and pain assessment to maintain certification and demonstrate its continued commitment to providing high-quality cancer care.

“We commend all of the certified practices for their achievement and dedication to transforming their practice. By doing the work to meet these standards and achieve certification, these practices are better equipped to succeed in a value-based system and deliver high-quality, equitable, evidence-based care for every single patient,” Lori J. Pierce, MD, FASTRO, FASCO, Chair of the Board of the Association for Clinical Oncology.

The pilot is slated to end in summer 2023. Over the next year, Memorial Cancer Institute will continue to work on quality assessment and improvement activities to maintain its certification.

About Memorial Cancer Institute

Part of Memorial Healthcare System, Memorial Cancer Institute is one of the largest cancer centers in Florida, treating more than 4,600 new patients each year. Memorial Cancer Institute, with research partner Florida Atlantic University, is one of only five programs designated by the Department of Health as a “Cancer Center of Excellence in Florida.” Memorial Cancer Institute will soon open a new freestanding facility in Pembroke Pines that will include radiation oncology, breast oncology, hematology-oncology, and Moffitt Malignant Hematology and Cellular Therapy at Memorial. It will also feature private infusion bays, a boutique and salon, conference center, physician offices, meditation room and a rooftop garden that will cement Memorial’s place as a home for world-class cancer treatment, research and high quality patient and family-centered care. To learn more, visit http://www.mhs.net/cancer.

Share article on social media or email: